Related Experiment Videos
A Dynamic Prognosis Model of Patients with Chronic Heart Failure: A Prospective Cohort Study Using Follow-Up Data and
Yujia Zhang1, Mengyi Dou2, Fengqin Ding3
1Clinical Medicine Program, The First Clinical Medical College, Shanxi Medical University, Taiyuan, Shanxi, 030001, People's Republic of China.
Vascular Health and Risk Management
|August 12, 2026
Summary
Dynamic models using longitudinal patient data improve chronic heart failure mortality risk prediction. Gated Recurrent Units (GRU) models, incorporating patient-reported outcomes, offer a promising tool for tailored interventions and risk assessment.
Area of Science:
- Cardiology
- Medical Informatics
- Machine Learning
Background:
- Traditional chronic heart failure (CHF) mortality prediction models use static data, limiting accuracy.
- Longitudinal follow-up data capture disease dynamics for improved risk prediction.
- Dynamic models offer potential for developing tailored interventions in CHF patients.
Purpose of the Study:
- To develop and validate a dynamic prediction model for 3-year all-cause mortality in CHF patients.
- To compare the performance of different machine learning models, including GRU, LSTM, MLP, and LR.
- To identify key predictors of mortality using interpretability techniques.
Main Methods:
- Enrolled 1,333 CHF patients, collecting patient-reported outcome (PRO) measures, lifestyle, and medication data.
- Developed and compared GRU, LSTM, MLP, and LR models using sequential data for 3-year mortality risk.
- Assessed model performance using AUC, accuracy, TNR, TPR, Brier score, and F1-score; utilized TimeSHAP for interpretability.
Main Results:
- The GRU model demonstrated superior predictive accuracy, with performance improving over time.
- Peak performance for the GRU model was achieved by 24 months (AUC: 0.765).
- Key predictors identified included CHF-PRO measures (physical condition, appetite, sleep, independence, anxiety), age, and NYHA class.
Conclusions:
- Longitudinal PRO data combined with GRU modeling provide a robust tool for predicting CHF mortality risk.
- A web-based decision support system was developed for practical risk score calculation.
- This dynamic approach supports evidence-based, tailored interventions for CHF management.
Related Concept Videos
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...